Adeptus Biotechnologies Corp. (ADPT) PT Raised to $22 at Morgan Stanley
Morgan Stanley analyst Kallum Titchmarsh raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $22.00 (from $20.00) while maintaining a Equalweight rating.